(Q44613034)

4 December 2017

Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone (English)

1 reference

4 December 2017

Pharmacokinetic and Pharmacodynamic Interactions of Oral Midazolam with Ketoconazole, Fluoxetine, Fluvoxamine, and Nefazodone (English)

1 reference

https://api.crossref.org/works/10.1177/0091270003259216

20 March 2024

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1177/0091270003259216

20 March 2024

1 reference

1 reference

Larry Ereshefsky

3

1 reference

4 December 2017

Michael Miller

4

1 reference

4 December 2017

Y. W Francis Lam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551182

20 March 2024

Cara L. Alfaro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551182

20 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14551182

20 March 2024

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270003259216

1 reference

https://api.crossref.org/works/10.1177/0091270003259216

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1177/0091270003259216

20 March 2024

1 reference

https://api.crossref.org/works/10.1177/0091270003259216

The Journal of Clinical Pharmacology

20 March 2024

published in

1 reference

4 December 2017

43

1 reference

4 December 2017

1274-1282

1 reference

4 December 2017

11

1 reference

In vitro and in vivo drug interactions involving human CYP3A.

4 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Alprazolam is another substrate for human cytochrome P450-3A isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259216

Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1177/0091270003259216

Fluoxetine impairs clearance of alprazolam but not of clonazepam

20 March 2024

7

1 reference

https://api.crossref.org/works/10.1177/0091270003259216

Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole

20 March 2024

19

1 reference

https://api.crossref.org/works/10.1177/0091270003259216

20 March 2024

Identifiers

1 reference

4 December 2017

1 reference